Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 71-30-7
2. 4-amino-2-hydroxypyrimidine
3. Cytosinimine
4. 4-aminopyrimidin-2(1h)-one
5. 2(1h)-pyrimidinone, 4-amino-
6. 4-amino-2(1h)-pyrimidinone
7. 6-aminopyrimidin-2(1h)-one
8. 4-aminopyrimidin-2-ol
9. 6-amino-1h-pyrimidin-2-one
10. Cyt
11. Mfcd00006034
12. 4-amino-1h-pyrimidin-2-one
13. 4-amino-2-oxo-1,2-dihydropyrimidine
14. Cytosin
15. Zytosin
16. 2(1h)-pyrimidinone, 6-amino-
17. Ai3-52281
18. 107646-83-3
19. Chebi:16040
20. Nsc-27787
21. 134434-40-5
22. 8j337d1hzy
23. 107646-84-4
24. 134434-39-2
25. 2(1h)-pyrimidinone, 3,4-dihydro-4-imino-, (e)- (9ci)
26. 4-aminopyrimidin-2-(1h)-one
27. 2(1h)-pyrimidinone, 3,4-dihydro-4-imino-, (z)- (9ci)
28. 4-aminopyrimidin-2(1h)-one (cytosine)
29. Smr000857094
30. 4-amino-2-pyrimidinol
31. Einecs 200-749-5
32. Nsc 27787
33. Aminopyrimidone
34. Unii-8j337d1hzy
35. Iminopyrimidinone
36. 3h-cytosine
37. Cytosine (8ci)
38. 4-amino-1,2-dihydropyrimidin-2-one
39. Lamivudine Impurity C
40. 2-pyrimidinol, 1,4-dihydro-4-imino-, (z)- (9ci)
41. 287484-45-1
42. Cytosine-[15n2]
43. Gemcitabine Impurity A
44. Cytosine, >=99%
45. 2(1h)-pyrimidinone, 4-amino- (9ci)
46. Cytosine [inci]
47. Lamivudine Impurity C Rs
48. Cytosine [mi]
49. 4-amino-pyrimidin-2-ol
50. 4-amino-2-oxypyrimidine
51. Bmse000180
52. Cytosine [usp-rs]
53. Cytosine [who-dd]
54. Epitope Id:167475
55. 4-amino-2(1h)pyrimidone
56. Ec 200-749-5
57. Schembl4059
58. 4-amino-2(1)-pyrimidone
59. Dsstox_cid_24456
60. Dsstox_rid_80242
61. 4-amino-2(1h)-pyrimidone
62. Dsstox_gsid_44456
63. 2-hydroxy-6-amino-pyrimidin
64. 4-amino-3h-pyrimidin-2-one
65. Mls001332635
66. Mls001332636
67. Chembl15913
68. 2-pyrimidinol, 1,6-dihydro-6-imino-, (e)- (9ci)
69. Gtpl8490
70. Dtxsid4044456
71. Hms2233n21
72. Hms3369n05
73. Zinc895210
74. Cytosine, >=99.0% (hplc)
75. Act01668
76. Albb-021996
77. Bcp22793
78. Hy-i0626
79. Nsc27787
80. Str01426
81. Tox21_302139
82. S4893
83. Stk366767
84. Stl455080
85. 6-amino-1,2-dihydropyrimidin-2-one
86. Akos000120336
87. Akos005443393
88. Akos015896942
89. Ac-2489
90. Am83918
91. Bcp9000005
92. Ccg-266052
93. Cs-w020703
94. 6-amino-1h-pyrimidin-2-one;cytosine
95. Cas-71-30-7
96. Cid 5274263
97. Sri-2354-05
98. Ncgc00247019-01
99. Ncgc00255926-01
100. Bp-20183
101. Cytosine, Vetec(tm) Reagent Grade, 99%
102. Nci60_012445
103. Sy001643
104. 4-imino-3,4-dihydropyrimidin-2(1h)-one
105. Db-029615
106. Lamivudine Impurity E [ep Impurity]
107. Ft-0617471
108. Lamivudine Impurity C [usp Impurity]
109. 71c307
110. C00380
111. 006c034
112. 2-pyrimidinol,1,6-dihydro-6-imino-,(e)-(9ci)
113. A837149
114. Q178425
115. 2(1h)-pyrimidinone,3,4-dihydro-4-imino-,(e)-(9ci)
116. Cba1d098-c5ab-46ce-aac6-754572886eb2
117. Z256707830
118. Cytosine, United States Pharmacopeia (usp) Reference Standard
119. Cytosine, Pharmaceutical Secondary Standard; Certified Reference Material
120. Gemcitabine Impurity A, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 111.10 g/mol |
|---|---|
| Molecular Formula | C4H5N3O |
| XLogP3 | -1.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 111.043261792 g/mol |
| Monoisotopic Mass | 111.043261792 g/mol |
| Topological Polar Surface Area | 67.5 Ų |
| Heavy Atom Count | 8 |
| Formal Charge | 0 |
| Complexity | 170 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
18.5
> 200
5,834.1k
108.1M
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|---|---|---|
| INDIA | 56,57,329.68 | 16.3 | > 200 |
| SINGAPORE | 1,10,200.00 | 129.4 | 11 - 50 |
| INDIA | 64,098.00 | 15.2 | <10 |
| CHINA | 1,666.40 | 27.6 | <10 |
| NETHERLANDS | 54.20 | 1,962.3 | <10 |
| GERMANY | 11.00 | 691.9 | <10 |
| SWITZERLAND | 436.30 | 469.9 | <10 |
| UNITED STATES | 11.00 | 862.2 | <10 |
| INDIA | 278.80 | 144.8 | <10 |
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
38
PharmaCompass offers a list of Cytosine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cytosine manufacturer or Cytosine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cytosine manufacturer or Cytosine supplier.
PharmaCompass also assists you with knowing the Cytosine API Price utilized in the formulation of products. Cytosine API Price is not always fixed or binding as the Cytosine Price is obtained through a variety of data sources. The Cytosine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cytosine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cytosine, including repackagers and relabelers. The FDA regulates Cytosine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cytosine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cytosine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cytosine supplier is an individual or a company that provides Cytosine active pharmaceutical ingredient (API) or Cytosine finished formulations upon request. The Cytosine suppliers may include Cytosine API manufacturers, exporters, distributors and traders.
click here to find a list of Cytosine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Cytosine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cytosine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cytosine GMP manufacturer or Cytosine GMP API supplier for your needs.
A Cytosine CoA (Certificate of Analysis) is a formal document that attests to Cytosine's compliance with Cytosine specifications and serves as a tool for batch-level quality control.
Cytosine CoA mostly includes findings from lab analyses of a specific batch. For each Cytosine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cytosine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cytosine EP), Cytosine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cytosine USP).
